Aurora Cannabis Stock Forecast, Price & News

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ACB shares have decreased by 51.0% and is now trading at $5.05.
View which stocks have been most impacted by COVID-19.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 3 sell ratings, 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Aurora Cannabis.

Aurora Cannabis Inc (NYSE:ACB) posted its earnings results on Thursday, November, 14th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.36) by $0.48. The company had revenue of $57.02 million for the quarter, compared to analyst estimates of $72.82 million. Aurora Cannabis had a negative return on equity of 8.55% and a negative net margin of 442.62%.
View Aurora Cannabis' earnings history.

Shares of Aurora Cannabis reverse split on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

Aurora Cannabis updated its first quarter 2021 After-Hours earnings guidance on Tuesday, September, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $43.278-46.163 million.

17 analysts have issued 1 year target prices for Aurora Cannabis' shares. Their forecasts range from $8.00 to $24.00. On average, they expect Aurora Cannabis' stock price to reach $14.03 in the next twelve months. This suggests a possible upside of 177.9% from the stock's current price.
View analysts' price targets for Aurora Cannabis.

Aurora Cannabis saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 23,380,000 shares, an increase of 18.6% from the August 31st total of 19,710,000 shares. Based on an average daily trading volume, of 4,330,000 shares, the days-to-cover ratio is presently 5.4 days. Approximately 20.9% of the company's shares are sold short.
View Aurora Cannabis' Short Interest.

Some companies that are related to Aurora Cannabis include Cronos Group (CRON), USANA Health Sciences (USNA), Aphria (APHA), Aphria (APHA), Tilray (TLRY), Canopy Rivers (RIV), Chromadex (CDXC), Mediwound (MDWD), Charlie's (CHUC), Natural Alternatives International (NAII), Happiness Biotech Group (HAPP), FSD Pharma (HUGE), Mannatech (MTEX), True Drinks (TRUU) and Sundial Growers (SNDL).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), NVIDIA (NVDA), HEXO (HEXO), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and KushCo (KSHB).

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Aurora Cannabis' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.57%), Think Investments LP (0.54%), TD Asset Management Inc. (0.29%), Swiss National Bank (0.21%), Bank of America Corp DE (0.21%) and UBS Group AG (0.09%).

ACB stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Swiss National Bank, TD Asset Management Inc., Goldman Sachs Group Inc., Bank of America Corp DE, CIBC Asset Management Inc, State of Wisconsin Investment Board, and Commonwealth Equity Services LLC.

ACB stock was purchased by a variety of institutional investors in the last quarter, including Think Investments LP, Virtu Financial LLC, Kessler Investment Group LLC, Berman Capital Advisors LLC, Harbor Advisors LLC, and Captrust Financial Advisors.

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACB stock can currently be purchased for approximately $5.05.

Aurora Cannabis has a market capitalization of $582.96 million and generates $215.10 million in revenue each year. The company earns $-219,670,000.00 in net income (profit) each year or ($2.64) on an earnings per share basis. Aurora Cannabis employs 2,779 workers across the globe.

The official website for Aurora Cannabis is auroramj.com.

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]